Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: A randomized study comparing two different doses

Tumori

Volumn 88, Issue 4, 2002, Pages 277-280

  Ulutin, H Cüneyt ^a   Arpaci, Fikret ^a   Pak, Yücel ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Anorexia; Cachexia; Megestrol acetate; Non small cell lung cancer

Indexed keywords

APPETITE STIMULANT; CORTICOSTEROID; MEGESTROL ACETATE;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BONE METASTASIS; CACHEXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DOSE CALCULATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ERYTHEMA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SUPERIOR CAVA VEIN SYNDROME; TREATMENT OUTCOME; TURKEY (REPUBLIC); VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036658691     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160208800406     Document Type: Article

References (32)

1. Heber D, Byerley LO, Chi J, Grosvenor M, Bergman RN, Coleman M, Chelobowski RT: Pathophysiology of malnutrition in the adult cancer patient. Cancer, 58: 1867-1873, 1986.
2. Heber D, Tchekmedyian NS: Pathophysiology of cancer: hormonal and metabolic abnormalities. Oncology, 49: 28-31, 1992.
3. Nixon DW, Moffitt S, Lawson DH, Ansley J, Lynn MJ, Kutner MH, Heymsfield SB, Lynn MJ, Wesley M, Yancey R, Rudman D: Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep, 65: 121-128, 1981.
4. Aisner J, Tchekmedyian NS, Tait N, Novak M: Studies of high-dose megestrol acetate: Potential applications in cachexia. Semin Oncol, 15: 68-75, 1988.
5. Tchekmedyian NS, Tait N, Moody M, Greco FA, Aisner J: Appetite stimulation with megestrol acetate in cachectic patients. Semin Oncol, 4: 37-43, 1986.
6. Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R: Supportive treatment with megestrol acetate during radio(chemo)therapy in patients with tumors in the head-neck area. A randomized study. Strahlenther Onkol, 172: 162-168, 1996.
7. Rowland KM, Loprinzi CL, Shaw EG, Maksymiuk AW, Kuross SA, Jung SH, Kugler JW, Tschetter LK, Ghosh C, Schaefer PL, Owen D, Washburn JH Jr, Webb TA, Mailliard JA, Jett JR: Randomized double-blind placebo controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol, 14: 135-141, 1996.
8. Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R: Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy. Eur J Cancer, 33: 75-79, 1997.
9. Tchekmedyian NS, Zahyna D, Halpert C, Heber D: Clinical aspects of nutrition in advanced cancer. Oncology, 49: 3-7, 1992.
10. Freyer G, Catimel G, Merrouche Y: Synthetic progestational hormones in the treatment of neoplastic cachexia. Rev Med Interna, 17: 79-84, 1996.
11. Skarlos DV, Fountzilas G, Pavlidis N, Beer M, Makrantonakis P, Aravantinos G, Pantelakos P, Tsavaris N, Karpasitis N, Kosmidis P: Megestrol acetatate in cancer patients with anorexia and weight loss: a Hellenic co-operative oncology group study. Acta Oncol, 32: 37-41, 1993.
12. De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, Caraceni A: Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial. Eur J Cancer, 34: 1705-1709, 1998.
13. Westman G, Bergman B, Albertsson M, Kadar L, Gustavsson G, Thaning L, Andersson M, Straumits A, Jeppson B, Linden CJ, Ewers SB, Andersson H, Mercke C, Hafstrom L, Birck O, Orgum P: Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomized, multicentre trial. Eur J Cancer, 35: 586-595, 1999.
14. Gebbia V, Testa A, Gebbia N: Prospective randomized trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Br J Cancer, 73: 1576-1580, 1996.
15. Bruera E, MacDonald RN: Asthenia in patients with advanced cancer. J Pain Symp Manag, 9: 265-268, 1988.
16. De Wys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med, 69: 491-497, 1980.
17. Bruera E: Clinical management of anorexia and cachexia in patients with advanced cancer. Oncology, 49: 35-42, 1992.
18. Teichmann AT, Wander HE, Wieland H: Wirkungen von Medroxyprogesteronacetat auf Lipid- und Lipoproteinkonzentrationen. In: Neue Erkenntnisse zum Wirkungsmechanismus von Medroxyprogestronacetat, Seeber S, Jonat W, Kreinberg R, Pollow K (Eds), pp 83, Zuckschwerdt, Munich, 1986.
19. Hamburger A, Parnes H, Gordon GB, Shantz LM, O'Donnell KA, Aisner J: Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro. Semin Oncol, 15: 76-78, 1988.
20. Tchekmedyian NS, Tait N, Moody M, Aisner J: High-dose megestrol acetate: a possible treatment for cachexia. JAMA, 257: 1195-1198, 1987.
21. Loprinzi CL, Ellison NM, Schaid DJ, Krook JE, Athmann LM, Dose AM, Mailliard JA, Johnson PS, Ebbert LP, Geeraerts LH: A controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst, 82: 1127-1132, 1990.
22. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN: A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer, 66: 1279-1282, 1990.
23. Feliu J, Gonzáles-Barón M, Berrocal A, Artal A, Ordónez A, Garrido P, Zamora P, Garcia de Paredes ML, Montero JM: Usefulness of megestrol acetate in cancer cachexia and anorexia: a placebo-controlled study. Am J Clin Oncol, 15: 436-440, 1992.
24. Tchekmedyian NS, Hickman RN, Siau J, Greco FA, Keller J, Browder H: Megestrol acetate in cancer anorexia and weight loss. Cancer, 69: 1268-1274, 1992.
25. Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J, Summers N, Brown B, Dulude H, Gallant G: Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Cancer Prev Control, 2: 74-78, 1998.
26. Strang P: The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients. Anticancer Res, 17: 657-662, 1997.
27. Miller AA, Becher R, Schmidt CG: Plasma concentrations of medroxyprogesterone acetate and megestrol acetate during long-term follow up in patients treated for metastatic breast cancer. J Cancer Res Clin Oncol, 114: 186-190, 1988.
28. Heckmayr M, Gatzemeier U: Treatment of cancer weight loss in patients with advanced lung cancer. Oncology, 49: 32-34, 1992.
29. Buntzel J, Kuttner K: Value of megestrol acetate in treatment of cachexia in head-neck tumors. Laryngorhinootologie, 74: 504-507, 1995.
30. Beller E, Tattersall M, Lumley T, Levi J, Dalley D, Olver I, Page J, Abdi E, Wynne C, Friedlander M, Boadle D, Wheeler H, Margrie S, Simes RJ: Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomized placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group. Ann Oncol, 8: 277-283, 1997.
31. Vadell C, Segui MA, Gimenez-Arnau JM, Morales S, Cirera L, Bestit I: Anticachetic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Am J Clin Oncol, 21: 347-351, 1998.
32. Schmoll E: Risks and benefits of various therapies for cancer anorexia. Oncology, 15: 436-440, 1992.